Unique advantages of nanomaterials in drug delivery and therapy against viruses

ABSTRACT

Viruses have caused some of most deadly epidemics and pandemics of humanity. They can cause major health problems, the collapse of the health and economic systems, as well as have negative social and psychological implications. Although science has aided in the management of some viruses, it still requires additional research on new and emerging viruses. The virus SARS-CoV-2 has caused the COVID-19 pandemic leading to the death of many people globally. Several vaccinations have been developed to try to eradicate the virus;however, due to the high mutation rate of the virus, vaccines are still rigorously tested in research and trials. Nanotechnology is a pretty modern technology that offers the potential to treat viruses. For the introduction of advanced antiviral medicines and vaccines, research in this field is becoming increasingly crucial. Furthermore, in a pandemic situation, employing nanomaterials to regulate drug distribution can be a fantastic method to make them successful across a broad range of activity. This book chapter is aimed to highlight recent studies and new technologies on the use of nanomaterials as antiviral therapy, focusing on the drug delivery system, its principles, potential, and economic viability. Because we are in the midst of a COVID-19 epidemic, this research is critical in determining the potential of nanotechnology in medicine, as well as future prospects for drug delivery and nanotherapies generated from NPs of promising nanomaterials. © 2022 Elsevier Inc. All rights reserved.